ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2317

Protein Phosphatase 5 (PP5) Regulates Methylation Sensitive Gene Expression in CD4+ T Cells

Dipak R. Patel, Gabriela Gorelik and Bruce C. Richardson, Internal Medicine, University of Michigan, Ann Arbor, MI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Epigenetics, KIR (Killer Ig like receptor), methylation and methyltransferase, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: CD4+CD28- T cells are enriched in chronic inflammatory diseases like rheumatoid arthritis (RA) and lupus.  They are cytotoxic and resistant to apoptosis.  Compared to CD28+ cells, CD28- CD4 T cells over-express killer immunoglobulin-like receptors (KIRs), perforin, and other molecules that are expected to contribute to their pro-inflammatory phenotype.  These genes are regulated by DNA methylation, so they are over-expressed by CD4 T cells that are demethylated in vitro.  This is a result of decreased signaling through the ERK and JNK pathways.  This consequently decreases activity of the DNA methyltransferase enzymes (DNMTs) responsible for DNA methylation.  Protein phosphatase 5 (PP5) is a stress induced regulator of gene expression in multiple signaling pathways, including ERK, JNK, and those involved in aging.  It is expressed in CD4+CD28-, but not CD4+CD28+ T cells.  We hypothesized that PP5 is over-expressed in CD4+ T cells in patients with RA and lupus, and that over-expressing PP5 in CD4 T cells from healthy donors will induce expression of methylation sensitive genes unique to CD4+CD28- T cells. 

Methods: CD4+ T cells were isolated from healthy controls and patients with RA and lupus, and PP5 mRNA expression was measured by RT-PCR.  To study the effects of PP5 on methylation sensitive genes, PBMCs from healthy donors were stimulated with phytohemagglutinin (PHA) and cultured for 3 days with IL-2.  CD4+ T cells were then isolated by negative selection, transfected (Amaxa Nucleofector) with constructs encoding GFP and PP5 or GFP alone, and cultured an additional 24-72 hours.  Expression of DNMT1, KIR, and perforin was assessed by RT-PCR in sorted CD4+GFP+ T cells.  DNMT1 expression was measured 24 hours after transfection, and KIR and perforin were analyzed 72 hours after transfection.  KIR protein expression was also measured by flow cytometry with unsorted cells 72 hours after transfection.   

Results: Compared to CD4+ T cells from healthy controls, PP5 mRNA is over-expressed in CD4+ T cells from patients with lupus (1.97 fold change ±0.18 SEM, p=0.03) and RA (1.6±0.2,  p=0.06).  When transfected into CD4+ T cells from healthy donors, PP5 increased KIR mRNA expression (2DL4 gene, 2.4±0.7, n=3, p=0.04) and CD70 mRNA expression (1.38±0.07, n=3, p=0.03).  PP5 transfection also increased the percentage of cells expressing KIR proteins on their surface (33±7% with control vs. 62±7% with PP5, n=7, p<0.01).  Finally, PP5 caused a corresponding 20±8% decrease (n=3, p=0.05) in DNMT1 mRNA expression.

Conclusion: CD4+CD28- T cells, which are enriched in RA and lupus, over-express methylation sensitive genes that contribute to their pro-inflammatory phenotype.  These data demonstrate, for the first time, that protein phosphatase 5 (PP5) contributes to the regulation of methylation sensitive genes in CD4+ T cells.  Specifically, PP5 increases expression of KIR and perforin, and it decreases expression of DNMT1.  Its effects on other methylation sensitive genes, including CD70 and IFN-g, are currently being studied.  PP5 has not been studied in T cells before, and it potentially links aging and DNA methylation with the pathogenesis of multiple rheumatologic disorders.


Disclosure:

D. R. Patel,
None;

G. Gorelik,
None;

B. C. Richardson,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protein-phosphatase-5-pp5-regulates-methylation-sensitive-gene-expression-in-cd4-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology